Page 2 - Roivant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Decheng Capital LLC Takes Position in Roivant Sciences Ltd (NASDAQ:ROIV)

Decheng Capital LLC Takes Position in Roivant Sciences Ltd (NASDAQ:ROIV)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Dynamic technology lab private ltdCovestor ltdExchange commissionInvestment advisersNews ratings for roivant sciences dailyRoivant sciencesGoldman sachs groupAllspring global investments holdingsHeadlands technologiesDeutsche bank aktiengesellschaftRoivant sciences price performanceRoivant sciences company profileWolfe researchQuarter for roivant sciencesRoivant sciences ltdDecheng capital

CinRx Pharma Corrals $73M to Continue Hub and Spoke Model of Startup Formation

CinRx Pharma Corrals $73M to Continue Hub and Spoke Model of Startup Formation
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

United statesCinrx pharmaCincor pharmaBridgebio pharmaJon isaacsohnRoivant sciencesPuretech healthRetromer therapeutics

Weiss Asset Management LP Has $142,000 Stock Holdings in Roivant Sciences Ltd (NASDAQ:ROIV)

Weiss Asset Management LP Has $142,000 Stock Holdings in Roivant Sciences Ltd (NASDAQ:ROIV)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Roivant sciences ltdDeerfield management companylp seriesCitigroup incQuarter for roivant sciencesRoivant sciences stock performanceRoivant sciences company profileWolfe researchDeutsche bank aktiengesellschaftGoldman sachs groupNews ratings for roivant sciences dailyRoivant sciencesMorgan stanleyFirst turn managementWeiss asset managementFree reportAsset management

Weiss Asset Management LP Sells 7,329 Shares of Roivant Sciences Ltd (NASDAQ:ROIV)

Weiss Asset Management LP Sells 7,329 Shares of Roivant Sciences Ltd (NASDAQ:ROIV)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Dynamic technology lab private ltdRoivant sciencesNews ratings for roivant sciences dailyDeutsche bank aktiengesellschaftGoldman sachs groupInvestment advisersHeadlands technologiesRoivant sciences stock downRoivant sciences company profileWolfe researchCovestor ltdExchange commissionAllspring global investments holdingsQuarter for roivant sciencesRoivant sciences ltdWeiss asset management

Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024

29.05.2024 - Following a recently completed Type B meeting with the FDA, Immunovant is on track to initiate 4 to 5 potentially registrational studies for its lead asset IMVT-1402 in endocrinology, neurology, and other therapeutic areas over this fiscal year .

Chau chengExchange commissionNeurology clinical development updatesDue to roivant sciences ltdGeneral clinical development updatesEndocrinology clinical development updatesImmunovant incClinical development updatesThyroid eye diseaseInsulin growth factorFiscal fourth quarter ended marchFiscal year ended marchPrivate securities litigation reform actAnnual reportRoivant sciences